GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
322.41B
PRECX
Price
$18.93
Change
+$0.07 (+0.37%)
Updated
Aug 6 closing price
Net Assets
1.05B
Interact to see
Advertisement

GFACX vs PRECX

Header iconGFACX vs PRECX Comparison
Open Charts GFACX vs PRECXBanner chart's image
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets322.41B
PGIM Jennison Blend C
Price$18.93
Change+$0.07 (+0.37%)
VolumeN/A
Net Assets1.05B
GFACX vs PRECX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. PRECX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and PRECX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 322B vs. PRECX (1.05B). GFACX (0.00) and PRECX (0.00) have matching dividends . GFACX was incepted earlier than PRECX: GFACX (24 years) vs PRECX (31 years). PRECX (1.89) is less costly to investors than GFACX (1.36). PRECX is a more actively managed with annual turnover of: 47.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than PRECX: GFACX (250) vs PRECX (1000). GFACX annual gain was more profitable for investors over the last year : 18.41 vs. PRECX (-0.63). GFACX return over 5 years is better than : 33.13 vs. PRECX (0.27).
GFACXPRECXGFACX / PRECX
Total Expense Ratio1.361.8972%
Annual Report Gross Expense Ratio1.361.8972%
Fund Existence24 years31 years-
Gain YTD12.1712.278534%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets322B1.05B30,608%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.41-0.63-2,912%
Returns for 3 years39.6317.58225%
Returns for 5 years33.130.2712,465%
Returns for 10 years67.85-6.63-1,023%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial